Funded Tech Companies
CARGO Therapeutics
Wondering who provided funding to CARGO Therapeutics? Nextech, Ally Bridge Group and Piper Heartland joined the equity holders in this biopharmaceutical company.
Company Overview
Company Name
CARGO Therapeutics
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
1900 Alameda De Las Pulgas 350
San Mateo, CA 94403
USA
San Mateo, CA 94403
USA
Phone
Undisclosed
Website
Email Address
Company Background Information
Overview
CARGO Therapeutics is engineering best-in-class CAR T-cell therapy to overcome resistance to cancer treatment and address barriers to access so that more patients may benefit from potentially curative therapies. CARGO is on a mission to outsmart cancer by advancing a new generation of best-in-class chimeric antigen receptor (CAR) T-cell therapies. Despite advances made by commercially available autologous CARs, these treatments are curative for fewer than half of all cancer patients. In addition, far too many patients are unable to access these potentially curative therapies due to other challenges, including manufacturing, supply constraints, slow turnaround time and reimbursement hurdles. The team at CARGO is intensely focused on pursuing novel solutions to achieve better cancer treatment outcomes and experiences.
Last Transaction
3/1/2023
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Company Investors
- Nextech
- Ally Bridge Group
- Piper Heartland
- Third Rock Ventures
- Wellington Management Company
- Samsara BioCapital
- RTW Investments
- Cormorant Asset Management
- Perceptive Advisors
- T. Rowe Price
- Janus Henderson Investors
Browse more funded tech companies:
Share this article
About Our VC Deals Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs